Chad Smith Selected Research

Chad Smith Research Topics

3	Sleep Deprivation 01/2021 - 10/2018
2	Multiple Sclerosis 10/2023 - 01/2023
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Cognitive Dysfunction 01/2019 - 10/2018
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2023
1	Autoimmune Diseases of the Nervous System 11/2023
1	Autoimmune Diseases (Autoimmune Disease) 10/2023
1	Neuroinflammatory Diseases 07/2023
1	Frontotemporal Dementia With Motor Neuron Disease 07/2023
1	Disease Progression 01/2023
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Endophthalmitis (Ophthalmia) 10/2018
1	Cataract (Cataracts) 10/2018
1	Huntington Disease (Huntington's Disease) 07/2013
1	Cystic Fibrosis (Mucoviscidosis) 03/2011

3	InflammasomesIBA 07/2023 - 01/2019
2	AntigensIBA 11/2023 - 10/2023
2	AntibodiesIBA 10/2023 - 01/2023
2	PolyphenolsIBA 01/2019 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 07/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2023
1	N-Methylaspartate (NMDA)IBA 11/2023
1	Natalizumab (Tysabri)FDA Link 01/2023
1	formycin diphosphate (FDP)IBA 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 10/2018
1	Peptide Initiation Factors (Initiation Factor)IBA 10/2018
1	TOR Serine-Threonine KinasesIBA 10/2018
1	Moxifloxacin (Avelox)FDA Link 10/2018
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 10/2018
1	polyglutamineIBA 07/2013

3	Therapeutics 01/2023 - 03/2011